Opsonophagocytic and Bactericidal Activity Mediated by Purified IgG Subclass Antibodies After Vaccination with the Norwegian Group B Meningococcal Vaccine
- 1 April 1998
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 47 (4) , 388-396
- https://doi.org/10.1046/j.1365-3083.1998.00319.x
Abstract
To study how the different immunoglobulin (Ig)G subclass antibodies may confer protection against systemic meningococcal disease, we isolated IgG1, IgG2 and IgG3 antibodies from plasma from vaccinees immunized with the Norwegian meningococcal outer membrane vesicle vaccine. Four IgG1, one IgG2 and four IgG3 preparations were purified. The IgG2 and IgG3 subclass preparations were free from contaminating subclasses, whereas the IgG1 preparations contained from 0 to 14% of IgG2 and/or IgG3. Immunoblotting against whole-cell meningococcal antigens showed broad specificities of the various preparations, both within and between subclasses. These subclass preparations were tested for opsonophagocytic and bactericidal activity. As targets we used two different variants of the meningococcal vaccine strain, with low (44/76-SL) and high (44/76-1) expression of the outer membrane protein Opc. Using polymorphonuclear leucocytes as effector cells in the presence of human complement, all three IgG subclass preparations revealed high, and similar, opsonophagocytic activities against 44/76-SL, whereas against 44/76-1 the IgG2 preparation showed a reduced activity and most IgG3 preparations were slightly more active than the IgG1 preparations. Regarding bactericidal activity, all the three subclasses were highly active against 44/76-SL. Against 44/76-1 the bactericidal activities were somewhat more varied: all IgG1 and three IgG3 preparations exhibited higher activities than against 44/76-SL. Due to the low concentration in the IgG2 preparations, only a weak activity was seen against 44/76-1. One IgG3 preparation that was highly opsonophagocytic revealed no bactericidal activity against either of the two bacterial variants examined. In conclusion, we have shown that the IgG subclass effector functions differ from person to person, but that antibodies of IgG1, IgG2 and IgG3 subclasses, judged by their behaviour in the functional tests, may all contribute to protection against meningococcal disease.Keywords
This publication has 25 references indexed in Scilit:
- Opsonophagocytic Activity Induced by Chimeric Antibodies of the Four Human IgG Subclasses With or Without Help from ComplementScandinavian Journal of Immunology, 1994
- Human IgG Fc receptor heterogeneity: molecular aspects and clinical implicationsImmunology Today, 1993
- Relationship ofin vitrophagocytosis of serotype 14Streptococcus pneumoniaeto specific class and IgG subclass antibody levels in healthy adultsClinical and Experimental Immunology, 1993
- Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge regionMolecular Immunology, 1992
- Human IgG subclass pattern of inducing complement‐mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentrationEuropean Journal of Immunology, 1991
- The IgG Subclass Pattern of Complement Activation Depends on Epitope Density and Antibody and Complement ConcentrationScandinavian Journal of Immunology, 1989
- Interaction of human IgG chimeric antibodies with the human FcRI and FcRII receptors: Requirements for antibody-mediated host cell-target cell interactionMolecular Immunology, 1989
- Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q.The Journal of Experimental Medicine, 1988
- Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.The Journal of Experimental Medicine, 1987
- Relationship between the Papain Sensitivity of Human γG Immunoglobulins and their Heavy Chain SubclassNature, 1968